Lowell Blake & Associates Inc. Abbott Laboratories Transaction History

Lowell Blake & Associates Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$105.0 - $114.42 $318,675 - $347,264	-3,035 Closed	0 $0
Q3 2020 Oct 22, 2020	BUY	$91.64 - $111.29 $3,207 - $3,895	35 Added 1.17%	3,035 $330,000
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $38,285 - $49,000	-500 Reduced 14.29%	3,000 $274,000
Q4 2019 Jul 01, 2020	BUY	$78.51 - $87.4 $274,785 - $305,900	3,500 New	3,500 $304,000

3,186

1.35B

8.62M

7.18M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Lowell Blake & Associates Inc., based on Form 13F filings with the SEC.

Stay updated on Lowell Blake & Associates Inc. with notifications on news.